Pharmacology for Nurses · Heart Failure Drugs
Heart Failure
On this page 9 sections
In 30 seconds
Heart failure is not one disease but a clinical syndrome: the heart cannot pump enough blood to meet the body's demands, or can only do so at abnormally high filling pressures. It is the final common pathway of many cardiovascular conditions — coronary artery disease, long-standing hypertension, valvular disease, cardiomyopathy — and is most common in older adults.
Three ideas anchor this chapter. First, heart failure results from a weak pump (impaired contraction) or a stiff pump (impaired filling), and the two behave differently. Second, the body's compensation — the RAAS and the sympathetic nervous system — helps briefly but becomes harmful over time, which is why most heart failure drugs work by blocking these systems. Third, symptoms come from two directions: Congestion Fluid backing up behind the failing ventricle Full entry → (fluid backing up) and low output (not enough blood reaching organs). The drugs in this chapter — RAAS blockers, beta blockers, SGLT2 inhibitors, and diuretics — each target one piece of this picture.
Why this matters
Heart failure is a leading cause of hospitalization in adults, with high rates of disability and mortality. Nurses are central to its management: they administer most of the drugs in this chapter, monitor daily weights and vital signs, catch early signs of worsening, and teach people to self-manage between visits. The pharmacology only makes sense through the physiology — understanding why the RAAS is overactive explains why an ACE inhibitor helps, and understanding congestion explains why daily weight is the key home monitor. Heart failure pharmacology is high-yield on the NCLEX and in practice.
Safety note: This study guide is an educational draft — drug classes and mechanisms only. Doses, schedules, and administration decisions are intentionally not provided. Always verify drug choices, dosing, monitoring, and contraindications against current references, the institutional formulary, and prescriber orders before any clinical action.
The college version
Core Concepts
What heart failure is — and is not
The name misleads: heart failure does not mean the heart has stopped (that is cardiac arrest) — it means the pump cannot keep up with demand. Two broad mechanisms produce this:
- Systolic dysfunction: the ventricle contracts weakly and empties poorly.
- Diastolic dysfunction: the ventricle is stiff, fills poorly, and requires abnormally high filling pressure that backs up into the lungs.
Ejection fraction: the key measurement
Ejection fraction (EF) The percentage of blood pumped out with each beat Full entry → is the percentage of blood in the ventricle ejected with each beat, measured by echocardiography:
- HFrEF — reduced ejection fraction: low EF (roughly ≤40%). The pump is weak.
- HFpEF — preserved ejection fraction: EF looks normal (roughly ≥50%) but filling is impaired by stiffness; linked to hypertension, diabetes, obesity, and aging.
- HFmrEF — mildly reduced ejection fraction: EF between the two (roughly 41–49%).
Cutoffs are conventions that shift with guidelines — check current references. The distinction matters because the drug-evidence base is strongest in HFrEF.
Compensation: helpful at first, harmful over time
When the heart underperforms, the body activates survival responses that make sense in an emergency but backfire chronically:
- RAAS activation. Reduced blood flow to the kidneys triggers renin release, starting a cascade (next topic) that ends in angiotensin II and aldosterone: vasoconstriction plus sodium and water retention. That supports a suddenly failing heart, but chronically it raises Preload Stretch on the ventricle before it contracts Full entry → (ventricular stretch before contraction) and Afterload Resistance the ventricle must push against (the resistance the heart pushes against), forcing a weak pump to work harder.
- Sympathetic (adrenergic) activation. Catecholamines raise heart rate and contractility — short-term support that becomes toxic, driving Remodeling Long-term change in heart shape and tissue Full entry →, arrhythmias, and worsening failure.
- Ventricular remodeling. Over time the heart muscle changes shape — hypertrophy, dilation, fibrosis — the structural reason heart failure progresses even when the original cause is controlled.
- Natriuretic peptides (ANP, BNP). The heart's counter-regulatory hormones promote vasodilation and sodium excretion. Because BNP rises as the ventricle stretches, it is used as a biomarker to support diagnosis.
The takeaway: the most effective heart failure drugs are neurohormonal blockers — they interrupt RAAS and sympathetic signaling rather than "strengthening" the pump.
Congestion vs. low output: the two symptom families
- "Backward" failure (congestion): blood backs up behind the failing ventricle. Left-sided congestion causes pulmonary symptoms — dyspnea, Orthopnea Difficulty breathing when lying flat; relieved by sitting up Full entry →, paroxysmal nocturnal dyspnea, crackles; right-sided congestion causes peripheral edema, ascites, jugular venous distention, and hepatic congestion. Right-sided failure is often secondary to left-sided failure.
- "Forward" failure (low output): organs receive too little blood — fatigue, exercise intolerance, weakness, cool extremities, and possible worsening kidney function.
Most acutely decompensated people present with congestion; weight gain over days often precedes symptoms — why daily weighing is a cornerstone of self-monitoring.
Classifying severity: stages and functional class
Two complementary systems are used together: ACC/AHA stages (A–D) track disease progression (A = at risk, B = structural disease without symptoms, C = structural disease with symptoms, D = refractory), while NYHA functional class (I–IV) rates current symptom burden (I = no limitation through IV = symptoms at rest). Stages say how far the disease has advanced; NYHA says how limited the person is right now. Both guide therapy and communication.
The treatment logic (overview)
Contemporary therapy follows the physiology: diuretics remove excess fluid; RAAS blockade (ACE inhibitors, ARBs, ARNI, MRAs) and beta-adrenergic blockade interrupt the harmful neurohormonal loops; SGLT2 inhibitors reduce hospitalizations. Devices and lifestyle measures (sodium awareness, daily weights) complete the picture, developed in the topics that follow.
Common Confusions
| Do Not Confuse | With | Difference |
|---|---|---|
| Heart failure | Cardiac arrest / "heart attack" | Heart failure is a chronic pump problem; cardiac arrest is electrical standstill; MI is blocked blood flow that can cause failure |
| HFrEF | HFpEF | HFrEF = weak contraction, low EF; HFpEF = stiff filling, normal EF — different mechanisms and treatment emphasis |
| ACC/AHA stage | NYHA class | Stage = how advanced the disease is (A–D); NYHA = how limited the person is right now (I–IV) |
| Left-sided failure | Right-sided failure | Left → pulmonary congestion (dyspnea, orthopnea); right → systemic congestion (edema, ascites) |
| Systolic dysfunction | Diastolic dysfunction | Systolic = poor ejection; diastolic = poor filling — both can produce congestion |
| Elevated BNP | Diagnosis of heart failure | BNP supports but does not establish the diagnosis; it rises with stretch from any cause |
Eli explains
The same idea, in plain words
Explain it like I’m 10
Your heart is a pump that pushes blood to every part of your body. In heart failure, the pump has gotten weak or too stiff, so blood backs up (swollen ankles, trouble breathing) and the body doesn't get enough blood (tiredness). The body tries to fix it by squeezing harder and holding onto salt and water — but that makes the tired pump work even harder. The medicines in this chapter take the strain off the pump and help the body let go of extra fluid.
Worked example
Mr. A., a person with HFrEF, calls the clinic feeling "more short of breath" with tight shoes. The nurse asks about daily weights first — the key screening question. He reports gaining about 3 kg over four days.
Walk through the reasoning:
- Connect findings to physiology. Rapid weight gain plus new dyspnea and edema = congestion: the failing left ventricle cannot handle the extra volume, so pressure backs into the lungs and the right heart.
- Rank urgency. Congestion with dyspnea is potentially serious. The nurse gathers more information (vital signs, oxygen saturation, ability to speak in sentences; chest pain or syncope would be emergency findings) and escalates to the provider.
- Teach while waiting. Review daily weighing, sodium awareness, and which symptoms warrant an urgent call. Any medication adjustment is the prescriber's decision, verified against orders and formulary.
The scenario shows why physiology matters: weight gain plus symptoms told the story without a dose table.
Key takeaways
- Heart failure ≠ cardiac arrest. It is a chronic syndrome of inadequate pumping, not a stopped heart.
- EF classifies the syndrome: HFrEF (weak pump, low EF), HFpEF (stiff pump, normal EF), HFmrEF (in between). Cutoffs shift — verify current guidelines.
- Compensation is double-edged. RAAS and sympathetic activation help briefly but drive remodeling and progression; most HF drugs block these systems.
- Two symptom families: congestion (dyspnea, edema, weight gain) vs. low output (fatigue, weakness); congestion dominates acute decompensation.
- Daily weight is the key home monitor: rapid gain = fluid accumulation, often before other symptoms.
- ACC/AHA stages (A–D) = disease progression; NYHA class (I–IV) = current functional limitation. Do not mix them up.
- BNP rises with ventricular stretch and supports diagnosis — not diagnostic alone.
Check yourself
6 review questions from the chapter. Try each one, then open the answer.
What is the difference between HFrEF and HFpEF in terms of ejection fraction and mechanism?
Show answer
HFrEF = low EF, weak contraction, poor emptying; HFpEF = preserved EF but stiff ventricles that fill under high pressure; HFmrEF sits between. (Exact cutoffs follow current guidelines — verify.)
Why do the body's own compensatory responses (RAAS, sympathetic activation) eventually harm a person with heart failure?
Show answer
They raise heart rate, contractility, vasoconstriction, and sodium/water retention — brief support that chronically raises preload and afterload, drives remodeling, and worsens arrhythmias.
Name the two "symptom families" of heart failure and one classic symptom of each.
Show answer
Congestion ("backward" failure): dyspnea, orthopnea, edema, weight gain, crackles. Low output ("forward" failure): fatigue, weakness, exercise intolerance, cool extremities.
Why is a daily weight more useful than an occasional blood pressure reading for detecting worsening heart failure?
Show answer
Weight gain reflects fluid accumulation and often appears days before other symptoms; blood pressure is a snapshot that misses the fluid picture.
What is the difference between ACC/AHA stages and NYHA functional class?
Show answer
Stages (A–D) track disease progression from at-risk to refractory; NYHA class (I–IV) describes current symptom limitation with activity.
True or false: "Heart failure" means the heart has stopped beating. Explain.
Show answer
False. Heart failure is a chronic syndrome of inadequate pumping; a stopped heart is cardiac arrest.
Study tools & related lessonsKey vocabulary · Related
Key vocabulary
- Ejection fraction (EF)
- The percentage of blood pumped out with each beat
- Preload
- Stretch on the ventricle before it contracts
- Afterload
- Resistance the ventricle must push against
- Remodeling
- Long-term change in heart shape and tissue
- Congestion
- Fluid backing up behind the failing ventricle
- Orthopnea
- Difficulty breathing when lying flat; relieved by sitting up
- Natriuretic peptides (ANP/BNP)
- Heart hormones that promote sodium loss and vasodilation
- NYHA class
- Rating of activity tolerance before symptoms
- ACC/AHA stage
- Rating of disease progression, from at risk to refractory
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.